Manipal Health Enterprises Ltd.
MANIPALHEALTHMainboard
Ask IPO
Overview
Manipal Health Enterprises Limited is a pan-India multispecialty hospital network operating 49 hospitals with 13,037 licensed beds across 14 states/UTs as of March 31, 2026, delivering care from outpatient services to complex tertiary and quaternary interventions, with a high-acuity specialty focus across cardiac sciences, oncology, neurosciences, gastro sciences, orthopedics and renal sciences (CONGO-R).
Opening Date
Jul 29, 2026
Closing Date
Jul 31, 2026
Listing Date
Aug 05, 2026
IPO Type
Mainboard
IPO Status
Upcoming
Issue Size
9275.22 Cr
Fresh Issue
8000 Cr
Offer for Sale
1275.22 Cr
Price Band
₹560 - ₹590
Lot Size
25
IPO Timeline
Financials
Revenue
Profit After Tax (PAT)
Use of IPO funds
Key Performance Indicator
P/E Ratio
75.93
EPS
7.77
ROE
10.57%
ROCE
21.88%
RONW
10.57%
Debt to Equity Ratio
—
PAT Margin
8.87%
EBITDA Margin
27.05%
P/B
8.13
Bull vs Bear
Bull case
- •
A large multi-city network can create a referral flywheel, where complex patients move within the same system, supporting steadier utilisation and specialist depth.
- •
Heavy focus on complex specialties can lift revenue per bed, since advanced procedures usually need better teams and equipment that smaller hospitals can’t easily replicate.
- •
A repeatable acquisition-integration playbook matters because scale comes faster, but only works long term if newly bought hospitals actually standardise quality and systems.
Bear case
- •
Karnataka concentration means a local disruption can hit the whole business, because fixed hospital costs continue even if patient volumes drop.
- •
Inpatient dependence is risky because lower occupancy quickly pressures margins, since staff, equipment and facilities costs don’t fall as fast as admissions.
- •
Integration-heavy strategy can backfire if approvals, TPA/insurer renewals, or systems migration get delayed, hurting collections and causing unexpected expenses.
Net takeaway
The long-term story is a scaled hospital network built around high-acuity specialties and expansion through acquisitions, which can deepen doctor talent and referrals over time. But it needs steady bed occupancy and smooth integration, especially after large deals, because hospital costs are sticky and rebranding can disrupt insurer empanelments. The one thing to monitor is utilisation and collections—watch occupancy and receivables trends to see if growth is translating into stable cash and margins.
Subscription Rate
Subscription data will be available once the IPO opens.
Application Details
Frequently Asked Questions about Manipal Health Enterprises Ltd.
Manipal Health Enterprises Limited is a pan-India multispecialty hospital network operating 49 hospitals with 13,037 licensed beds across 14 states/UTs as of March 31, 2026, delivering care from outpatient services to complex tertiary and quaternary interventions, with a high-acuity specialty focus across cardiac sciences, oncology, neurosciences, gastro sciences, orthopedics and renal sciences (CONGO-R).
The Manipal Health Enterprises Ltd. IPO is scheduled to open for subscription on Jul 29, 2026 and close on Jul 31, 2026. Investors can apply for shares during this period through eligible platforms.
The price band for the Manipal Health Enterprises Ltd. IPO is ₹560 to ₹590. Investors can place bids within this range once the issue opens.
The minimum lot size for the Manipal Health Enterprises Ltd. IPO is 25 shares. The minimum investment amount ₹14,750.
The total issue size of the Manipal Health Enterprises Ltd. IPO is approximately ₹9,275.22. Issue size represents the total value of shares offered to the public.
As per the latest available information, the Manipal Health Enterprises Ltd. IPO has been subscribed data will be available once the issue opens. Subscription levels can change significantly during the offer period.
The Grey Market Premium (GMP) for the Manipal Health Enterprises Ltd. IPO is ₹[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]. GMP reflects unofficial market sentiment and should not be considered a guarantee of listing performance.
The shares of Manipal Health Enterprises Ltd. are expected to list on stock exchanges on Aug 05, 2026, subject to completion of the allotment process and regulatory approvals.
The net proceeds from the Manipal Health Enterprises Ltd. IPO are proposed to be used for Our Company proposes to utilise the net proceeds of the Fresh Issue, i.e., Gross Proceeds of the Fresh Issue less our Company's share of the Offer related expenses ('Net Proceeds') towards the following objects:, Repayment/ prepayment, in full or in part, of certain outstanding borrowings and accrued interest thereon availed by one of our Material Subsidiaries, namely, Manipal Hospitals Private Limited, Acquisition of minority stake in our stepdown Subsidiary, Sahyadri Hospitals Private Limited, General corporate purposes.
Before applying for the Manipal Health Enterprises Ltd. IPO, investors generally review the company’s business model, financial performance, valuation, industry outlook, and risk factors mentioned in the offer document.
